Sotera Health (SHC) Financials

$12.16 -0.10 (-0.82%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$12.16 -0.01 (-0.04%)

As of 05/23/2025 05:02 PM Eastern

Annual Income Statements for Sotera Health

This table shows Sotera Health's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Income / (Loss) Attributable to Common Shareholders	44	51	-375	117	-39	-21
Consolidated Net Income / (Loss)	44	86	-375	117	-37	-20
Net Income / (Loss) Continuing Operations	44	86	-375	117	-37	-20
Total Pre-Tax Income	114	106	-243	176	-39	-0.92
Total Operating Income	298	277	248	257	206	184
Total Gross Profit	602	577	557	519	444	395
Total Revenue	1,100	1,049	0.00	931	818	778
Operating Revenue	1,100	1,049	-	931	818	778
Total Cost of Revenue	498	472	447	413	375	383
Operating Cost of Revenue	498	472	56	413	375	383
Total Operating Expenses	305	300	246	262	238	212
Selling, General & Admin Expense	243	237	246	198	179	147
Amortization Expense	62	64	-	64	59	59
Total Other Income / (Expense), net	-184	-136	-83	-81	-245	-185
Interest Expense	24	0.00	-	21	44	30
Interest & Investment Income	-165	-143	-90	-74	-215	-158
Other Income / (Expense), net	5.11	7.21	6.30	14	15	3.38
Income Tax Expense	69	55	-9.54	59	-1.37	20
Basic Earnings per Share	$0.16	$0.18	($0.83)	$0.41	($0.16)	($0.09)
Weighted Average Basic Shares Outstanding	282.78M	281.01M	280.10M	279.23M	237.70M	232.40M
Diluted Earnings per Share	$0.16	$0.18	($0.83)	$0.41	($0.16)	($0.09)
Weighted Average Diluted Shares Outstanding	284.91M	283.22M	280.10M	279.38M	237.70M	232.40M
Weighted Average Basic & Diluted Shares Outstanding	283.47M	282.83M	282.42M	282.93M	-	-

This table shows Sotera Health's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-13	12	17	8.75	6.32	39	-14	24	2.84	-462	25
Consolidated Net Income / (Loss)	-13	12	17	8.75	6.32	74	-14	24	2.84	-462	25
Net Income / (Loss) Continuing Operations	-13	12	17	8.75	6.32	74	-14	24	2.84	-462	25
Total Pre-Tax Income	-15	45	43	15	11	66	0.47	34	5.40	-379	42
Total Operating Income	26	87	81	77	53	104	76	63	33	60	63
Total Gross Profit	135	164	158	153	127	180	146	140	112	142	136
Total Revenue	255	290	285	277	248	310	263	255	221	-752	249
Operating Revenue	255	290	285	277	248	310	263	255	221	-	249
Total Cost of Revenue	119	126	127	124	121	130	117	116	109	110	113
Operating Cost of Revenue	119	126	127	124	121	130	117	116	109	-281	113
Total Operating Expenses	109	77	78	76	74	76	70	76	78	19	73
Selling, General & Admin Expense	63	62	62	61	58	60	54	60	62	66	57
Amortization Expense	15	15	16	15	16	16	16	16	16	-	16
Other Special Charges / (Income)	31	-	-	-	-	-	-	-	-	-	-
Total Other Income / (Expense), net	-41	-42	-38	-62	-42	-3.35	-76	-29	-28	-31	-21
Interest & Investment Income	-41	-41	-42	-40	-42	-43	-41	-31	-29	-32	-23
Other Income / (Expense), net	-0.05	-0.52	3.89	2.13	-0.39	39	-35	2.01	0.91	1.60	2.25
Income Tax Expense	-1.56	33	26	6.39	4.69	27	14	11	2.56	-59	17
Basic Earnings per Share	($0.05)	$0.05	$0.06	$0.03	$0.02	$0.14	($0.05)	$0.08	$0.01	($1.14)	$0.09
Weighted Average Basic Shares Outstanding	283.56M	282.78M	283.06M	282.89M	281.91M	281.01M	281.11M	280.89M	280.69M	280.10M	280.14M
Diluted Earnings per Share	($0.05)	$0.05	$0.06	$0.03	$0.02	$0.14	($0.05)	$0.08	$0.01	($1.14)	$0.09
Weighted Average Diluted Shares Outstanding	283.56M	284.91M	285.56M	284.54M	284.06M	283.22M	281.11M	283.15M	282.98M	280.10M	280.17M
Weighted Average Basic & Diluted Shares Outstanding	283.86M	283.47M	283.24M	283.21M	283.07M	282.83M	282.62M	282.62M	282.52M	282.42M	282.11M

This table details how cash moves in and out of Sotera Health's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Change in Cash & Equivalents	-23	-95	289	4.47	39	-34
Net Cash From Operating Activities	224	-148	278	282	121	149
Net Cash From Continuing Operating Activities	224	-148	278	282	121	149
Net Income / (Loss) Continuing Operations	44	51	-234	117	-37	-20
Consolidated Net Income / (Loss)	44	51	-234	117	-37	-20
Depreciation Expense	84	77	64	64	63	67
Amortization Expense	87	90	87	93	92	88
Non-Cash Adjustments To Reconcile Net Income	4.88	-337	430	25	41	42
Changes in Operating Assets and Liabilities, net	4.01	-29	-70	-18	-38	-27
Net Cash From Investing Activities	-179	-215	-182	-160	-159	-57
Net Cash From Continuing Investing Activities	-179	-215	-182	-160	-159	-57
Purchase of Property, Plant & Equipment	-179	-215	-182	-102	-54	-57
Other Investing Activities, net	0.07	0.07	0.03	-0.70	0.00	0.00
Net Cash From Financing Activities	-51	266	198	-117	73	-126
Net Cash From Continuing Financing Activities	-51	266	198	-117	73	-126
Repayment of Debt	-2,299	-230	-1.85	-107	-1,199	-2,579
Issuance of Debt	2,259	500	200	0.00	150	3,145
Other Financing Activities, net	-11	-4.09	-0.39	-1.43	0.00	0.00
Effect of Exchange Rate Changes	-17	2.04	-4.46	0.04	4.11	0.49
Cash Interest Paid	180	174	76	59	211	151
Cash Income Taxes Paid	66	50	75	52	24	45

This table details how cash moves in and out of Sotera Health's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	27	-30	61	-15	-39	49	-18	-390	264	231	24
Net Cash From Operating Activities	56	56	97	61	9.70	113	42	-337	34	102	68
Net Cash From Continuing Operating Activities	56	56	97	61	9.70	113	42	-337	34	102	68
Net Income / (Loss) Continuing Operations	-13	12	17	8.75	6.32	39	-14	24	2.84	-320	25
Consolidated Net Income / (Loss)	-13	12	17	8.75	6.32	39	-14	24	2.84	-320	25
Depreciation Expense	22	21	23	20	20	21	18	19	19	17	16
Amortization Expense	20	21	21	22	23	23	23	23	23	21	22
Non-Cash Adjustments To Reconcile Net Income	28	-4.80	11	31	-32	11	41	-396	7.33	416	-3.81
Changes in Operating Assets and Liabilities, net	-1.47	6.60	25	-20	-7.84	20	-26	-5.50	-18	-32	8.97
Net Cash From Investing Activities	-20	-66	-36	-42	-35	-65	-52	-53	-45	-72	-39
Net Cash From Continuing Investing Activities	-20	-66	-36	-42	-35	-65	-52	-53	-45	-72	-39
Purchase of Property, Plant & Equipment	-20	-66	-36	-42	-35	-65	-52	-53	-45	-72	-39
Other Investing Activities, net	0.04	-	0.04	-	0.04	-	0.04	-	0.03	-0.45	0.03
Net Cash From Financing Activities	-8.09	-6.55	-2.65	-29	-12	-3.79	-3.45	-0.71	274	199	-0.40
Net Cash From Continuing Financing Activities	-8.09	-6.55	-2.65	-29	-12	-3.79	-3.45	-0.71	274	199	-0.40
Repayment of Debt	-4.49	-2.12	-2.65	-2,289	-5.21	0.30	-3.45	-0.71	-226	-0.36	-0.40
Other Financing Activities, net	-3.60	-4.43	-	-	-6.74	-4.09	-	-	0.00	-	-
Effect of Exchange Rate Changes	-0.34	-13	2.28	-5.02	-1.74	4.62	-4.37	0.73	1.07	1.90	-4.07
Cash Interest Paid	47	37	32	41	70	23	72	43	35	11	23
Cash Income Taxes Paid	12	23	15	18	9.84	7.62	15	14	14	19	19

This table presents Sotera Health's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Total Assets	3,072	3,130	3,118	2,790	2,761
Total Current Assets	526	557	645	346	315
Cash & Equivalents	277	296	395	107	102
Restricted Cash	1.62	5.25	1.08	0.01	0.01
Accounts Receivable	140	148	118	108	92
Inventories, net	49	48	37	54	34
Prepaid Expenses	51	54	81	72	65
Current Deferred & Refundable Income Taxes	6.66	5.73	12	4.64	22
Plant, Property, & Equipment, net	1,037	947	775	651	610
Total Noncurrent Assets	1,509	1,626	1,698	1,793	1,836
Goodwill	1,081	1,111	1,102	1,120	1,116
Intangible Assets	318	416	491	599	643
Noncurrent Deferred & Refundable Income Taxes	2.87	4.99	4.10	5.89	8.42
Employee Benefit Assets	43	28	36	5.48	0.00
Other Noncurrent Operating Assets	65	65	65	53	55
Total Liabilities & Shareholders' Equity	3,072	3,130	3,118	2,790	2,761
Total Liabilities	2,667	2,687	2,767	2,203	2,307
Total Current Liabilities	191	231	792	161	141
Short-Term Debt	20	11	205	9.29	-
Accounts Payable	55	71	74	73	52
Accrued Expenses	90	122	490	62	61
Current Deferred Revenue	15	13	12	8.67	6.06
Current Deferred & Payable Income Tax Liabilities	7.56	4.15	5.87	6.70	10
Other Current Liabilities	2.92	8.77	4.62	1.78	11
Total Noncurrent Liabilities	2,476	2,456	1,976	2,042	2,152
Long-Term Debt	2,208	2,224	1,747	1,744	1,825
Capital Lease Obligations	95	64	57	41	-
Asset Retirement Reserve & Litigation Obligation	49	48	43	42	45
Noncurrent Deferred Revenue	17	19	19	21	21
Noncurrent Deferred & Payable Income Tax Liabilities	70	64	68	135	122
Noncurrent Employee Benefit Liabilities	7.86	8.44	7.91	11	48
Other Noncurrent Operating Liabilities	29	29	34	49	91
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	405	444	350	586	455
Total Preferred & Common Equity	405	444	350	586	452
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	405	444	350	586	452
Common Stock	1,247	1,218	1,192	1,175	1,169
Retained Earnings	-610	-654	-706	-472	-589
Treasury Stock	-23	-27	-30	-34	-34
Accumulated Other Comprehensive Income / (Loss)	-208	-93	-107	-84	-94

This table presents Sotera Health's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	3,098	3,149	3,058	3,060	3,037	3,075	3,414	2,811
Total Current Assets	555	564	498	487	520	547	924	421
Cash & Equivalents	304	307	246	261	245	263	648	164
Restricted Cash	1.69	1.74	1.67	1.69	7.58	7.79	12	0.99
Accounts Receivable	128	130	124	111	118	117	109	112
Inventories, net	61	54	58	51	38	42	47	37
Prepaid Expenses	55	57	57	54	84	91	87	82
Current Deferred & Refundable Income Taxes	5.14	14	12	8.29	27	26	20	25
Plant, Property, & Equipment, net	1,046	1,026	995	979	884	859	816	704
Total Noncurrent Assets	1,496	1,559	1,566	1,593	1,633	1,669	1,674	1,685
Goodwill	1,084	1,105	1,098	1,103	1,101	1,110	1,103	1,092
Intangible Assets	300	352	368	390	429	456	472	504
Noncurrent Deferred & Refundable Income Taxes	2.98	4.95	4.75	4.88	4.04	4.16	4.17	5.09
Employee Benefit Assets	44	33	31	30	39	39	37	9.86
Other Noncurrent Operating Assets	64	65	64	65	59	59	58	74
Total Liabilities & Shareholders' Equity	3,098	3,149	3,058	3,060	3,037	3,075	3,414	2,811
Total Liabilities	2,683	2,679	2,635	2,630	2,659	2,657	3,053	2,204
Total Current Liabilities	226	196	170	152	201	200	600	140
Short-Term Debt	20	20	16	10	12	12	20	7.72
Accounts Payable	70	71	64	62	57	56	62	61
Accrued Expenses	114	83	69	62	106	103	497	57
Current Deferred Revenue	14	11	13	13	13	14	15	5.35
Current Deferred & Payable Income Tax Liabilities	5.39	8.34	4.41	4.51	4.14	5.73	4.59	7.35
Other Current Liabilities	3.04	2.82	2.77	1.49	8.65	9.40	2.11	2.12
Total Noncurrent Liabilities	2,457	2,483	2,465	2,478	2,459	2,456	2,453	2,064
Long-Term Debt	2,205	2,211	2,214	2,225	2,223	2,222	2,222	1,747
Capital Lease Obligations	94	98	94	91	84	61	82	55
Asset Retirement Reserve & Litigation Obligation	50	49	48	48	44	44	43	44
Noncurrent Deferred Revenue	17	18	18	18	18	19	19	19
Noncurrent Deferred & Payable Income Tax Liabilities	54	64	54	60	69	68	63	152
Noncurrent Employee Benefit Liabilities	7.91	8.22	8.18	8.24	7.76	8.01	7.86	10
Other Noncurrent Operating Liabilities	29	35	30	28	12	33	15	38
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	414	470	423	429	377	418	361	607
Total Preferred & Common Equity	414	470	423	429	377	418	361	607
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	414	470	423	429	377	418	361	607
Common Stock	1,248	1,242	1,232	1,223	1,213	1,206	1,198	1,189
Retained Earnings	-623	-622	-639	-648	-693	-679	-703	-386
Treasury Stock	-21	-25	-25	-26	-28	-29	-29	-33
Accumulated Other Comprehensive Income / (Loss)	-189	-125	-145	-120	-114	-79	-105	-164

This table displays calculated financial ratios and metrics derived from Sotera Health's official financial filings.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Growth Metrics	-	-	-	-	-	-
Revenue Growth	4.88%	0.00%	-100.00%	13.85%	5.12%	0.00%
EBITDA Growth	5.04%	11.09%	-5.09%	13.78%	9.90%	0.00%
EBIT Growth	6.63%	11.49%	-5.89%	22.63%	18.01%	0.00%
NOPAT Growth	-13.45%	-22.88%	1.59%	18.66%	12.21%	0.00%
Net Income Growth	-48.60%	123.01%	-420.57%	412.40%	-83.55%	0.00%
EPS Growth	-11.11%	121.69%	-302.44%	356.25%	-77.78%	0.00%
Operating Cash Flow Growth	251.74%	-153.15%	-1.27%	133.48%	-19.09%	0.00%
Free Cash Flow Firm Growth	131.16%	-172.38%	456.08%	104.20%	0.00%	0.00%
Invested Capital Growth	0.37%	24.33%	-13.29%	3.94%	0.00%	0.00%
Revenue Q/Q Growth	-1.79%	5.92%	-100.00%	2.69%	0.00%	0.00%
EBITDA Q/Q Growth	-4.70%	1,123.75%	-3.38%	4.23%	0.00%	0.00%
EBIT Q/Q Growth	-6.69%	238.05%	-4.71%	6.72%	0.00%	0.00%
NOPAT Q/Q Growth	-29.82%	-17.74%	8.52%	53.03%	0.00%	0.00%
Net Income Q/Q Growth	-37.25%	128.13%	-407.38%	210.35%	0.00%	0.00%
EPS Q/Q Growth	-36.00%	116.36%	-293.02%	272.73%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-20.39%	7.05%	14.68%	18.78%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	-9.34%	-1,074.23%	420.01%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-1.66%	-0.12%	-12.81%	3.73%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	54.73%	55.00%	0.00%	55.68%	54.22%	50.81%
EBITDA Margin	43.04%	42.97%	0.00%	45.91%	45.94%	43.94%
Operating Margin	27.05%	26.37%	0.00%	27.56%	25.18%	23.59%
EBIT Margin	27.51%	27.06%	0.00%	29.05%	26.97%	24.02%
Profit (Net Income) Margin	4.03%	8.23%	0.00%	12.57%	-4.58%	-2.62%
Tax Burden Percent	38.99%	81.47%	154.44%	66.65%	96.48%	2,229.80%
Interest Burden Percent	37.62%	37.35%	-95.47%	64.94%	-17.61%	-0.49%
Effective Tax Rate	61.01%	51.54%	0.00%	33.35%	0.00%	0.00%
Return on Invested Capital (ROIC)	4.75%	6.09%	0.00%	7.71%	13.24%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	1.20%	3.45%	0.00%	4.53%	-7.85%	0.00%
Return on Net Nonoperating Assets (RNNOA)	5.72%	15.67%	0.00%	14.80%	-29.74%	0.00%
Return on Equity (ROE)	10.46%	21.76%	-80.20%	22.51%	-16.50%	0.00%
Cash Return on Invested Capital (CROIC)	4.38%	-15.60%	22.46%	3.84%	-186.76%	0.00%
Operating Return on Assets (OROA)	9.76%	9.09%	0.00%	9.75%	7.99%	0.00%
Return on Assets (ROA)	1.43%	2.76%	0.00%	4.22%	-1.36%	0.00%
Return on Common Equity (ROCE)	10.46%	21.76%	-80.20%	22.46%	-16.41%	0.00%
Return on Equity Simple (ROE_SIMPLE)	10.96%	19.47%	-107.20%	19.98%	-8.29%	0.00%
Net Operating Profit after Tax (NOPAT)	116	134	174	171	144	129
NOPAT Margin	10.54%	12.78%	0.00%	18.37%	17.63%	16.51%
Net Nonoperating Expense Percent (NNEP)	3.55%	2.64%	33.39%	3.18%	21.09%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	4.25%	4.89%	7.37%	-	-	-
Cost of Revenue to Revenue	45.27%	45.00%	0.00%	44.32%	45.78%	49.19%
SG&A Expenses to Revenue	22.05%	22.56%	0.00%	21.27%	21.82%	18.95%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	27.69%	28.64%	0.00%	28.12%	29.04%	27.22%
Earnings before Interest and Taxes (EBIT)	303	284	255	271	221	187
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	474	451	406	428	376	342
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	9.57	10.73	6.71	11.37	2.83	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.52	4.54	0.00	7.15	1.56	1.38
Price to Earnings (P/E)	87.27	92.69	0.00	57.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.15%	1.08%	0.00%	1.75%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.42	2.77	2.02	3.68	1.37	0.00
Enterprise Value to Revenue (EV/Rev)	5.38	6.44	0.00	8.95	3.65	0.00
Enterprise Value to EBITDA (EV/EBITDA)	12.50	14.99	9.76	19.50	7.96	0.00
Enterprise Value to EBIT (EV/EBIT)	19.55	23.81	15.56	30.82	13.55	0.00
Enterprise Value to NOPAT (EV/NOPAT)	51.01	50.41	22.79	48.74	20.73	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	26.41	0.00	14.26	29.62	24.79	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	55.30	0.00	8.35	97.71	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	5.74	5.18	5.74	3.06	4.01	0.00
Long-Term Debt to Equity	5.69	5.16	5.15	3.04	4.01	0.00
Financial Leverage	4.76	4.55	3.51	3.27	3.79	0.00
Leverage Ratio	7.31	7.87	6.31	5.33	6.07	0.00
Compound Leverage Factor	2.75	2.94	-6.02	3.46	-1.07	0.00
Debt to Total Capital	85.16%	83.82%	85.15%	75.37%	80.06%	0.00%
Short-Term Debt to Total Capital	0.73%	0.39%	8.68%	0.39%	0.00%	0.00%
Long-Term Debt to Total Capital	84.43%	83.43%	76.48%	74.98%	80.06%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.10%	0.00%
Common Equity to Total Capital	14.84%	16.18%	14.85%	24.63%	19.84%	0.00%
Debt to EBITDA	4.91	5.10	4.95	4.19	4.86	0.00
Net Debt to EBITDA	4.32	4.43	3.97	3.92	4.55	0.00
Long-Term Debt to EBITDA	4.86	5.07	4.44	4.17	4.86	0.00
Debt to NOPAT	20.02	17.14	11.55	10.48	12.65	0.00
Net Debt to NOPAT	17.62	14.89	9.28	9.80	11.85	0.00
Long-Term Debt to NOPAT	19.85	17.06	10.38	10.43	12.65	0.00
Altman Z-Score	1.41	1.53	0.41	2.31	0.67	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.22%	0.50%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	2.75	2.42	0.81	2.15	2.24	0.00
Quick Ratio	2.19	1.93	0.65	1.33	1.38	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	107	-344	475	85	-2,033	0.00
Operating Cash Flow to CapEx	125.18%	-68.72%	152.41%	275.59%	225.36%	260.30%
Free Cash Flow to Firm to Interest Expense	4.43	0.00	0.00	4.13	-45.94	0.00
Operating Cash Flow to Interest Expense	9.28	0.00	0.00	13.61	2.72	4.94
Operating Cash Flow Less CapEx to Interest Expense	1.87	0.00	0.00	8.67	1.52	3.04
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.35	0.34	0.00	0.34	0.30	0.00
Accounts Receivable Turnover	7.64	7.88	0.00	9.32	8.92	0.00
Inventory Turnover	10.22	11.05	9.77	9.34	10.99	0.00
Fixed Asset Turnover	1.11	1.22	0.00	1.48	1.34	0.00
Accounts Payable Turnover	7.90	6.50	6.08	6.59	7.15	0.00
Days Sales Outstanding (DSO)	47.77	46.30	0.00	39.17	40.93	0.00
Days Inventory Outstanding (DIO)	35.71	33.03	37.36	39.07	33.22	0.00
Days Payable Outstanding (DPO)	46.21	56.12	60.06	55.38	51.06	0.00
Cash Conversion Cycle (CCC)	37.27	23.21	0.00	22.86	23.09	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	2,449	2,440	1,963	2,263	2,178	0.00
Invested Capital Turnover	0.45	0.48	0.00	0.42	0.75	0.00
Increase / (Decrease) in Invested Capital	9.01	478	-301	86	2,178	0.00
Enterprise Value (EV)	5,919	6,759	3,962	8,340	2,990	0.00
Market Capitalization	3,875	4,762	2,350	6,663	1,279	1,072
Book Value per Share	$1.43	$1.57	$1.24	$2.07	$1.90	$0.00
Tangible Book Value per Share	($3.51)	($3.83)	($4.41)	($4.00)	($5.50)	$0.00
Total Capital	2,728	2,742	2,359	2,380	2,279	0.00
Total Debt	2,323	2,298	2,009	1,794	1,825	0.00
Total Long-Term Debt	2,303	2,287	1,804	1,784	1,825	0.00
Net Debt	2,044	1,997	1,612	1,677	1,709	0.00
Capital Expenditures (CapEx)	179	215	182	102	54	57
Debt-free, Cash-free Net Working Capital (DFCFNWC)	76	36	-338	87	72	0.00
Debt-free Net Working Capital (DFNWC)	355	337	58	194	174	0.00
Net Working Capital (NWC)	335	327	-147	185	174	0.00
Net Nonoperating Expense (NNE)	72	48	549	54	182	149
Net Nonoperating Obligations (NNO)	2,044	1,997	1,612	1,677	1,723	0.00
Total Depreciation and Amortization (D&A)	171	167	151	157	155	155
Debt-free, Cash-free Net Working Capital to Revenue	6.91%	3.40%	0.00%	9.36%	8.80%	0.00%
Debt-free Net Working Capital to Revenue	32.25%	32.15%	0.00%	20.84%	21.32%	0.00%
Net Working Capital to Revenue	30.45%	31.12%	0.00%	19.84%	21.32%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.16	$0.18	($0.83)	$0.41	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	282.78M	281.01M	280.10M	279.23M	0.00	0.00
Adjusted Diluted Earnings per Share	$0.16	$0.18	($0.83)	$0.41	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	284.91M	283.22M	280.10M	279.38M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	283.47M	282.83M	282.42M	282.93M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	208	194	174	171	144	133
Normalized NOPAT Margin	18.93%	18.46%	0.00%	18.37%	17.63%	17.03%
Pre Tax Income Margin	10.35%	10.10%	0.00%	18.86%	-4.75%	-0.12%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	12.53	0.00	0.00	13.08	4.99	6.20
NOPAT to Interest Expense	4.80	0.00	0.00	8.27	3.26	4.26
EBIT Less CapEx to Interest Expense	5.12	0.00	0.00	8.14	3.78	4.30
NOPAT Less CapEx to Interest Expense	-2.61	0.00	0.00	3.33	2.05	2.36
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	7.19%	0.00%	-3,383.94%
Augmented Payout Ratio	0.00%	0.00%	0.00%	7.19%	-90.69%	-3,383.94%

This table displays calculated financial ratios and metrics derived from Sotera Health's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.56%	-6.46%	8.47%	8.35%	12.51%	141.25%	5.82%	-4.26%	-6.83%	-411.75%	9.97%
EBITDA Growth	-28.85%	-31.28%	57.58%	13.12%	26.45%	87.23%	-20.67%	-2.93%	-18.70%	-12.48%	-1.73%
EBIT Growth	-50.64%	-39.56%	105.36%	21.03%	54.02%	132.04%	-37.20%	-9.13%	-38.44%	-16.92%	-0.25%
NOPAT Growth	-40.15%	-61.02%	101.45%	3.03%	73.90%	45.48%	-5,960.81%	-4.67%	-51.52%	3.45%	-13.94%
Net Income Growth	-309.71%	-83.28%	224.44%	-62.77%	122.48%	115.96%	-154.44%	-22.70%	-90.72%	-1,382.35%	-8.58%
EPS Growth	-350.00%	-64.29%	220.00%	-62.50%	100.00%	112.28%	-155.56%	-27.27%	-90.91%	-1,050.00%	-10.00%
Operating Cash Flow Growth	472.44%	-50.75%	132.87%	118.21%	-71.36%	10.99%	-38.26%	-677.42%	-32.21%	53.62%	-16.26%
Free Cash Flow Firm Growth	119.00%	103.57%	99.36%	89.29%	-232.50%	-221.41%	-7,606.69%	-196.71%	505.29%	861.00%	98.54%
Invested Capital Growth	-2.60%	0.37%	1.94%	2.23%	23.06%	24.33%	8.54%	5.95%	-13.34%	-13.29%	3.16%
Revenue Q/Q Growth	-12.29%	1.66%	3.21%	11.45%	-20.00%	17.88%	3.09%	15.73%	-12.32%	-402.41%	-6.73%
EBITDA Q/Q Growth	-46.86%	-0.39%	6.44%	26.30%	-36.83%	128.42%	-23.59%	41.18%	124.56%	-3.22%	-6.50%
EBIT Q/Q Growth	-69.92%	2.64%	6.93%	49.53%	-51.27%	248.74%	-36.98%	90.28%	109.90%	-5.62%	-8.81%
NOPAT Q/Q Growth	-23.50%	-25.38%	-27.91%	45.45%	-50.18%	102.77%	-5,232.20%	145.50%	-58.32%	11.61%	-16.52%
Net Income Q/Q Growth	-207.60%	-27.50%	94.17%	38.45%	-83.65%	639.39%	-158.10%	727.34%	100.89%	-1,939.80%	-17.52%
EPS Q/Q Growth	-200.00%	-16.67%	100.00%	50.00%	-85.71%	380.00%	-162.50%	700.00%	100.88%	-1,366.67%	-18.18%
Operating Cash Flow Q/Q Growth	-0.35%	-42.83%	58.99%	531.97%	-91.43%	170.31%	112.43%	-1,093.70%	-66.77%	50.38%	16.28%
Free Cash Flow Firm Q/Q Growth	457.79%	197.27%	-51.57%	97.69%	-4.85%	82.68%	-2,452.32%	-128.59%	-3.93%	1,199.28%	1.74%
Invested Capital Q/Q Growth	-0.89%	-1.66%	-0.30%	0.23%	2.13%	-0.12%	-0.01%	20.66%	3.18%	-12.81%	-2.39%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.21%	56.64%	55.36%	55.24%	51.22%	58.05%	55.47%	54.68%	50.55%	0.00%	54.69%
EBITDA Margin	26.77%	44.18%	45.09%	43.72%	38.58%	60.14%	31.04%	41.88%	34.33%	0.00%	41.40%
Operating Margin	10.25%	30.03%	28.20%	27.77%	21.43%	33.53%	28.92%	24.76%	15.13%	0.00%	25.41%
EBIT Margin	10.24%	29.85%	29.56%	28.54%	21.27%	46.20%	15.62%	25.55%	15.54%	0.00%	26.31%
Profit (Net Income) Margin	-5.21%	4.25%	5.95%	3.16%	2.55%	23.75%	-5.19%	9.21%	1.29%	0.00%	10.09%
Tax Burden Percent	89.46%	27.41%	39.76%	57.81%	57.41%	112.20%	-2,906.38%	68.18%	52.61%	121.96%	59.72%
Interest Burden Percent	-56.90%	51.91%	50.66%	19.18%	20.87%	45.82%	1.14%	52.88%	15.76%	-612.79%	64.20%
Effective Tax Rate	0.00%	72.59%	60.24%	42.19%	42.59%	41.10%	3,006.38%	31.82%	47.39%	0.00%	40.28%
Return on Invested Capital (ROIC)	3.23%	3.70%	5.09%	7.13%	5.86%	9.41%	-354.70%	6.94%	3.60%	0.00%	6.80%
ROIC Less NNEP Spread (ROIC-NNEP)	1.68%	3.13%	4.36%	5.40%	4.57%	10.10%	-236.21%	5.88%	2.73%	0.00%	6.03%
Return on Net Nonoperating Assets (RNNOA)	8.13%	14.91%	21.01%	26.31%	21.52%	45.91%	-890.40%	20.60%	9.13%	0.00%	17.58%
Return on Equity (ROE)	11.36%	18.62%	26.10%	33.44%	27.39%	55.33%	-1,245.10%	27.54%	12.73%	-80.20%	24.38%
Cash Return on Invested Capital (CROIC)	5.73%	4.38%	4.79%	3.25%	-14.23%	-15.60%	-1.25%	0.70%	21.62%	22.46%	4.12%
Operating Return on Assets (OROA)	3.68%	10.59%	10.71%	10.22%	7.08%	15.52%	5.29%	8.43%	4.91%	0.00%	9.41%
Return on Assets (ROA)	-1.87%	1.51%	2.16%	1.13%	0.85%	7.98%	-1.76%	3.04%	0.41%	0.00%	3.61%
Return on Common Equity (ROCE)	11.36%	18.62%	26.10%	33.44%	27.39%	55.33%	-1,245.10%	27.54%	12.73%	-80.20%	24.38%
Return on Equity Simple (ROE_SIMPLE)	5.99%	0.00%	15.05%	9.48%	12.78%	0.00%	-81.34%	-64.12%	-72.38%	0.00%	20.13%
Net Operating Profit after Tax (NOPAT)	18	24	32	44	31	61	-2,212	43	18	42	38
NOPAT Margin	7.18%	8.23%	11.21%	16.05%	12.30%	19.75%	-840.38%	16.88%	7.96%	0.00%	15.17%
Net Nonoperating Expense Percent (NNEP)	1.55%	0.57%	0.73%	1.74%	1.30%	-0.69%	-118.49%	1.06%	0.88%	30.62%	0.77%
Return On Investment Capital (ROIC_SIMPLE)	0.67%	0.88%	-	-	-	2.23%	-	-	-	1.79%	-
Cost of Revenue to Revenue	46.79%	43.36%	44.64%	44.76%	48.78%	41.95%	44.53%	45.32%	49.45%	0.00%	45.31%
SG&A Expenses to Revenue	24.78%	21.31%	21.72%	21.90%	23.45%	19.46%	20.56%	23.62%	28.07%	0.00%	22.96%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	42.96%	26.61%	27.15%	27.47%	29.79%	24.52%	26.55%	29.92%	35.42%	0.00%	29.28%
Earnings before Interest and Taxes (EBIT)	26	87	84	79	53	143	41	65	34	62	65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	68	128	129	121	96	187	82	107	76	100	103
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.98	9.57	10.06	7.95	7.90	10.73	11.22	12.72	14.01	6.71	3.18
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.99	3.52	4.22	3.06	3.15	4.54	4.27	5.45	5.12	0.00	1.94
Price to Earnings (P/E)	133.20	87.27	66.84	83.80	61.88	92.69	0.00	0.00	0.00	0.00	15.80
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.75%	1.15%	1.50%	1.19%	1.62%	1.08%	0.00%	0.00%	0.00%	0.00%	6.33%
Enterprise Value to Invested Capital (EV/IC)	2.19	2.42	2.71	2.18	2.19	2.77	2.58	3.01	3.32	2.02	1.59
Enterprise Value to Revenue (EV/Rev)	4.81	5.38	6.02	4.95	5.07	6.44	6.36	7.53	6.81	0.00	3.60
Enterprise Value to EBITDA (EV/EBITDA)	11.93	12.50	13.58	12.08	12.52	14.99	0.00	0.00	0.00	9.76	8.51
Enterprise Value to EBIT (EV/EBIT)	19.27	19.55	20.81	19.33	20.41	23.81	0.00	0.00	0.00	15.56	13.37
Enterprise Value to NOPAT (EV/NOPAT)	69.74	51.01	40.82	40.34	37.46	50.41	38.65	47.73	42.08	22.79	22.31
Enterprise Value to Operating Cash Flow (EV/OCF)	19.70	26.41	23.97	24.05	0.00	0.00	0.00	0.00	25.67	14.26	14.74
Enterprise Value to Free Cash Flow (EV/FCFF)	37.74	55.30	57.18	67.74	0.00	0.00	0.00	440.72	14.25	8.35	39.15
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	5.60	5.74	4.95	5.49	5.42	5.18	6.14	5.49	6.44	5.74	2.98
Long-Term Debt to Equity	5.55	5.69	4.91	5.46	5.39	5.16	6.11	5.46	6.38	5.15	2.97
Financial Leverage	4.83	4.76	4.82	4.87	4.71	4.55	3.77	3.50	3.35	3.51	2.91
Leverage Ratio	7.30	7.31	7.30	7.29	8.19	7.87	5.94	5.61	6.23	6.31	4.90
Compound Leverage Factor	-4.15	3.79	3.70	1.40	1.71	3.61	0.07	2.97	0.98	-38.66	3.15
Debt to Total Capital	84.85%	85.16%	83.20%	84.60%	84.41%	83.82%	86.00%	84.58%	86.55%	85.15%	74.89%
Short-Term Debt to Total Capital	0.73%	0.73%	0.72%	0.58%	0.37%	0.39%	0.43%	0.45%	0.73%	8.68%	0.32%
Long-Term Debt to Total Capital	84.12%	84.43%	82.49%	84.02%	84.05%	83.43%	85.57%	84.13%	85.82%	76.48%	74.57%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	15.15%	14.84%	16.80%	15.40%	15.59%	16.18%	14.00%	15.42%	13.45%	14.85%	25.11%
Debt to EBITDA	5.20	4.91	4.69	5.16	5.34	5.10	-52.64	-100.88	-118.99	4.95	4.31
Net Debt to EBITDA	4.51	4.32	4.07	4.61	4.73	4.43	-46.90	-89.00	-85.19	3.97	3.91
Long-Term Debt to EBITDA	5.16	4.86	4.65	5.13	5.31	5.07	-52.37	-100.34	-117.99	4.44	4.29
Debt to NOPAT	30.41	20.02	14.08	17.24	15.96	17.14	14.22	14.91	14.55	11.55	11.29
Net Debt to NOPAT	26.40	17.62	12.22	15.40	14.16	14.89	12.67	13.15	10.42	9.28	10.26
Long-Term Debt to NOPAT	30.15	19.85	13.96	17.12	15.89	17.06	14.15	14.83	14.43	10.38	11.25
Altman Z-Score	0.97	1.18	1.37	1.05	1.02	1.38	1.13	1.42	1.14	0.20	0.88
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.46	2.75	2.88	2.93	3.20	2.42	2.59	2.73	1.54	0.81	3.00
Quick Ratio	1.91	2.19	2.23	2.18	2.44	1.93	1.81	1.90	1.26	0.65	1.97
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	83	15	-15	-10	-436	-416	-2,404	-94	329	343	-31
Operating Cash Flow to CapEx	278.75%	84.59%	267.81%	146.22%	27.80%	174.50%	80.46%	-633.45%	75.27%	142.08%	173.79%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-218.40	-0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	1,392.19	2.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	872.34	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.36	0.35	0.36	0.36	0.33	0.34	0.34	0.33	0.32	0.00	0.36
Accounts Receivable Turnover	9.26	7.64	9.02	9.11	9.78	7.88	8.61	8.23	8.82	0.00	9.56
Inventory Turnover	8.83	10.22	10.97	9.85	9.87	11.05	12.04	10.94	9.69	9.77	11.90
Fixed Asset Turnover	1.09	1.11	1.17	1.18	1.20	1.22	1.25	1.25	1.33	0.00	1.50
Accounts Payable Turnover	7.54	7.90	7.86	8.20	7.84	6.50	7.67	7.40	7.65	6.08	7.89
Days Sales Outstanding (DSO)	39.43	47.77	40.48	40.04	37.32	46.30	42.37	44.34	41.38	0.00	38.16
Days Inventory Outstanding (DIO)	41.34	35.71	33.26	37.07	36.97	33.03	30.32	33.35	37.66	37.36	30.68
Days Payable Outstanding (DPO)	48.43	46.21	46.45	44.52	46.56	56.12	47.60	49.30	47.74	60.06	46.25
Cash Conversion Cycle (CCC)	32.33	37.27	27.29	32.59	27.73	23.21	25.10	28.39	31.31	0.00	22.59
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,427	2,449	2,491	2,498	2,492	2,440	2,443	2,443	2,025	1,963	2,251
Invested Capital Turnover	0.45	0.45	0.45	0.44	0.48	0.48	0.42	0.41	0.45	0.00	0.45
Increase / (Decrease) in Invested Capital	-65	9.01	47	54	467	478	192	137	-312	-301	69
Enterprise Value (EV)	5,319	5,919	6,750	5,435	5,457	6,759	6,299	7,348	6,722	3,962	3,574
Market Capitalization	3,305	3,875	4,730	3,360	3,394	4,762	4,234	5,323	5,058	2,350	1,929
Book Value per Share	$1.46	$1.43	$1.66	$1.49	$1.52	$1.57	$1.34	$1.48	$1.28	$1.24	$2.14
Tangible Book Value per Share	($3.42)	($3.51)	($3.48)	($3.69)	($3.77)	($3.83)	($4.08)	($4.06)	($4.30)	($4.41)	($3.50)
Total Capital	2,734	2,728	2,799	2,746	2,755	2,742	2,696	2,714	2,685	2,359	2,416
Total Debt	2,319	2,323	2,329	2,323	2,326	2,298	2,318	2,296	2,324	2,009	1,809
Total Long-Term Debt	2,300	2,303	2,309	2,307	2,315	2,287	2,307	2,283	2,305	1,804	1,801
Net Debt	2,013	2,044	2,020	2,075	2,063	1,997	2,066	2,025	1,664	1,612	1,644
Capital Expenditures (CapEx)	20	66	36	42	35	65	52	53	45	72	39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	43	76	80	96	82	36	78	88	-317	-338	123
Debt-free Net Working Capital (DFNWC)	349	355	388	344	345	337	331	359	343	58	288
Net Working Capital (NWC)	329	335	368	328	335	327	319	346	324	-147	281
Net Nonoperating Expense (NNE)	32	12	15	36	24	-12	-2,198	20	15	504	13
Net Nonoperating Obligations (NNO)	2,013	2,044	2,020	2,075	2,063	1,997	2,066	2,025	1,664	1,612	1,644
Total Depreciation and Amortization (D&A)	42	42	44	42	43	43	41	42	41	38	38
Debt-free, Cash-free Net Working Capital to Revenue	3.87%	6.91%	7.11%	8.76%	7.63%	3.40%	7.89%	9.04%	-32.10%	0.00%	12.43%
Debt-free Net Working Capital to Revenue	31.52%	32.25%	34.64%	31.32%	32.03%	32.15%	33.38%	36.75%	34.75%	0.00%	29.04%
Net Working Capital to Revenue	29.73%	30.45%	32.85%	29.87%	31.09%	31.12%	32.21%	35.48%	32.77%	0.00%	28.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.05)	$0.05	$0.06	$0.03	$0.02	$0.14	($0.05)	$0.08	$0.01	($1.14)	$0.09
Adjusted Weighted Average Basic Shares Outstanding	283.56M	282.78M	283.06M	282.89M	281.91M	281.01M	281.11M	280.89M	280.69M	280.10M	280.14M
Adjusted Diluted Earnings per Share	($0.05)	$0.05	$0.06	$0.03	$0.02	$0.14	($0.05)	$0.08	$0.01	($1.14)	$0.09
Adjusted Weighted Average Diluted Shares Outstanding	283.56M	284.91M	285.56M	284.54M	284.06M	283.22M	281.11M	283.15M	282.98M	280.10M	280.17M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	283.86M	283.47M	283.24M	283.21M	283.07M	282.83M	282.62M	282.62M	282.52M	282.42M	282.11M
Normalized Net Operating Profit after Tax (NOPAT)	40	61	56	44	31	61	53	43	18	42	38
Normalized NOPAT Margin	15.69%	21.02%	19.74%	16.05%	12.30%	19.75%	20.24%	16.88%	7.96%	0.00%	15.17%
Pre Tax Income Margin	-5.82%	15.49%	14.98%	5.47%	4.44%	21.17%	0.18%	13.51%	2.45%	0.00%	16.89%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	1,205.66	3.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	457.25	1.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	685.81	1.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	-62.59	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Sotera Health's Financials

When does Sotera Health's fiscal year end?

According to the most recent income statement we have on file, Sotera Health's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Sotera Health's net income changed over the last 5 years?

Sotera Health's net income appears to be on a downward trend, with a most recent value of $44.40 million in 2024, falling from -$20.43 million in 2019. The previous period was $86.38 million in 2023. Find out what analysts predict for Sotera Health in the coming months.

What is Sotera Health's operating income?

Sotera Health's total operating income in 2024 was $297.63 million, based on the following breakdown:

Total Gross Profit: $602.30 million
Total Operating Expenses: $304.67 million

How has Sotera Health revenue changed over the last 5 years?

Over the last 5 years, Sotera Health's total revenue changed from $778.33 million in 2019 to $1.10 billion in 2024, a change of 41.4%.

How much debt does Sotera Health have?

Sotera Health's total liabilities were at $2.67 billion at the end of 2024, a 0.7% decrease from 2023, and a 15.6% increase since 2020.

How much cash does Sotera Health have?

In the past 4 years, Sotera Health's cash and equivalents has ranged from $102.45 million in 2020 to $395.21 million in 2022, and is currently $277.24 million as of their latest financial filing in 2024.

How has Sotera Health's book value per share changed over the last 5 years?

Over the last 5 years, Sotera Health's book value per share changed from 0.00 in 2019 to 1.43 in 2024, a change of 143.0%.

Related Companies

This page (NASDAQ:SHC) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sotera Health (SHC) Financials

Frequently Asked Questions About Sotera Health's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sotera Health (SHC) Financials

Annual Income Statements for Sotera Health

Quarterly Income Statements for Sotera Health

Annual Cash Flow Statements for Sotera Health

Quarterly Cash Flow Statements for Sotera Health

Annual Balance Sheets for Sotera Health

Quarterly Balance Sheets for Sotera Health

Annual Metrics And Ratios for Sotera Health

Quarterly Metrics And Ratios for Sotera Health

Frequently Asked Questions About Sotera Health's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools